Zinc-binding proteins (metallothionein and α-2 macroglobulin) and immunosenescence

Experimental Gerontology

Volumn 41, Issue 11, 2006, Pages 1094-1107

  Mocchegiani, Eugenio ^a   Costarelli, Laura ^a   Giacconi, Robertina ^a   Cipriano, Catia ^a   Muti, Elisa ^a   Malavolta, Marco ^a  

^a INRCA   (Italy)

Author keywords

2 Macroglobulin; Genetic marker; Immunosenescence; Metallothionein; Zinc

Indexed keywords

ALPHA 2 MACROGLOBULIN; BINDING PROTEIN; METALLOTHIONEIN; ZINC; ZINC FINGER PROTEIN;

AGING; ALZHEIMER DISEASE; ATHEROSCLEROSIS; CANCER CELL; CELL PROTECTION; CYTOTOXICITY; DNA POLYMORPHISM; DOWN SYNDROME; ENDOCRINE SYSTEM; HUMAN; IMMUNE DEFICIENCY; IMMUNE RESPONSE; IMMUNE SYSTEM; IMMUNOCOMPETENT CELL; IN VITRO STUDY; INNATE IMMUNITY; LONGEVITY; MOLECULAR EVOLUTION; MULTIPLE SCLEROSIS; NATURAL KILLER CELL; NONHUMAN; PLEIOTROPY; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN EXPRESSION; REVIEW; SENESCENCE; SURVIVAL RATE; THYMUS;

ADULT; AGED; AGING; ALPHA-MACROGLOBULINS; ANIMALS; DIETARY SUPPLEMENTS; HUMANS; IMMUNE SYSTEM; IMMUNITY, NATURAL; MALE; METALLOTHIONEIN; MICE; MODELS, IMMUNOLOGICAL; PROSTATIC NEOPLASMS; ZINC; ZINC FINGERS;

EID: 33751437558     PISSN: 05315565     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.exger.2006.08.010     Document Type: Review

References (131)

1. Abdel-Mageed A., and Agrawal K.C. Antisense down-regulation of metallothionein induces growth arrest and apoptosis in human breast carcinoma cells. Cancer Gene Ther. 4 (1997) 199-207
2. Abo T. Extrathymic pathways of T-cell differentiation: a primitive and fundamental immune system. Microbiol. Immunol. 37 (1993) 247-258
3. Abo T., Kawamura T., and Watanabe H. Physiological responses of extrathymic T cells in the liver. Immunol. Rev. 174 (2000) 135-149
4. Armstrong P.B. Proteases and protease inhibitors: a balance of activities in host-pathogen interaction. Immunobiology 211 (2006) 263-281
5. Ashcroft G.S., Herrick S.E., Tarnuzzer R.W., Horan M.A., Schultz G.S., and Ferguson M.W. Human ageing impairs injury-induced in vivo expression of tissue inhibitor of matrix metalloproteinases (TIMP)-1 and -2 proteins and mRNA. J. Pathol. 183 (1997) 169-176
6. Ashok B.T., and Ali R. The aging paradox: free radical theory of aging. Exp. Gerontol. 34 (1999) 293-303
7. Bach J.F., Dardenne M., and Chatenoud L. Immunomodulation of T cells by thymic hormone and monoclonal anti-T cell antibody. Transplant. Proc. 14 (1982) 509-512
8. Bao B., Prasad A.S., Beck F.W., and Godmere M. Zinc modulates mRNA levels of cytokines. Am. J. Physiol. Endocrinol. Metab. 285 (2003) E1095-E1102
9. Bardos P., and Bach J.F. Modulation of mouse natural killer cell activity by the serum thymic factor. Scand. J. Immunol. 16 (1982) 321-325
10. Beck F.W., Prasad A.S., Kaplan J., Fitzgerald J.T., and Brewer G.J. Changes in cytokine production and T cell subpopulations in experimentally induced zinc-deficient humans. Am. J. Physiol. 272 6 Pt 1 (1997) E1002-E1007
11. Blasco M.A. Telomeres and human disease: ageing, cancer and beyond. Nat. Rev. Genet. 6 (2005) 611-622
12. Bogden J.D., Oleske J.M., Lavenhar M.A., Munves E.M., Kemp F.W., Bruening K.S., Holding K.J., Denny T.N., Guarino M.A., and Holland B.K. Effects of one year of supplementation with zinc and other micronutrients on cellular immunity in the elderly. J. Am. Coll. Nutr. 9 (1990) 214-225
13. Borth W. Alpha 2-macroglobulin, a multifunctional binding protein with targeting characteristics. FASEB J. 6 (1992) 3345-3353
14. Borth W. Alpha 2-macroglobulin. A multifunctional binding and targeting protein with possible roles in immunity and autoimmunity. Ann. N. Y. Acad. Sci. 737 (1994) 267-272
15. Boukaiba N., Flament C., Acher S., Chappuis P., Piau A., Fusselier M., Dardenne M., and Lemonnier D. A physiological amount of zinc supplementation: effects on nutritional, lipid, and thymic status in an elderly population. Am. J. Clin. Nutr. 57 (1993) 566-572
16. Bruno L., Res P., Dessing M., Cella M., and Spits H. Identification of a committed T cell precursor population in adult human peripheral blood. J. Exp. Med. 185 (1997) 875-884
17. Bui L.M., Dressendorfer R.H., Keen C.L., Summary J.J., and Dubick M.A. Zinc status and interleukin-1 beta-induced alterations in mineral metabolism in rats. Proc. Soc. Exp. Biol. Med. 206 (1994) 438-444
18. Cai L., Satoh M., Tohyama C., and Cherian M.G. Metallothionein in radiation exposure: its induction and protective role. Toxicology 132 (1999) 85-98
19. Cakman I., Rohwer J., Schutz R.M., Kirchner H., and Rink L. Dysregulation between TH1 and TH2 T cell subpopulations in the elderly. Mech. Ageing Dev. 87 (1996) 197-209
20. Cakman I., Kirchner H., and Rink L. Zinc supplementation reconstitutes the production of interferon-alpha by leukocytes from elderly persons. J. Interferon Cytokine Res. 17 (1997) 469-472
21. Chandratilleke D., and Marsh J.A. The effect of thymulin on avian IL-2 receptor expression. Int. J. Immunopharmacol. 22 (2000) 887-896
22. Chiricolo M., Musa A.R., Monti D., Zannotti M., and Franceschi C. Enhanced DNA repair in lymphocytes of Down syndrome patients: the influence of zinc nutritional supplementation. Mutat. Res. 295 (1993) 105-111
23. Chu C.T., Howard G.C., Misra U.K., and Pizzo S.V. Alpha 2-macroglobulin: a sensor for proteolysis. Ann. N. Y. Acad. Sci. 737 (1994) 291-307
24. Cipriano C., Giacconi R., Muzzioli M., Gasparini N., Orlando F., Corradi A., Cabassi E., and Mocchegiani E. Metallothionein (I+II) confers, via c-myc, immune plasticity in oldest mice: model of partial hepatectomy/liver regeneration. Mech. Ageing Dev. 124 (2003) 877-886
25. Clegg M.S., Hanna L.A., Niles B.J., Momma T.Y., and Keen C.L. Zinc deficiency-induced cell death. IUBMB Life 57 (2005) 661-669
26. Coleman J.E. Zinc proteins: enzymes, storage proteins, transcription factors, and replication proteins. Annu. Rev. Biochem. 61 (1992) 897-946
27. Coto J.A., Hadden E.M., Sauro M., Zorn N., and Hadden J.W. Interleukin 1 regulates secretion of zinc-thymulin by human thymic epithelial cells and its action on T-lymphocyte proliferation and nuclear protein kinase C. Proc. Natl. Acad. Sci. USA 89 (1992) 7752-7756
28. Cui L., Takagi Y., Wasa M., Iiboshi Y., Inoue M., Khan J., Sando K., Nezu R., and Okada A. Zinc deficiency enhances interleukin-1alpha-induced metallothionein-1 expression in rats. J. Nutr. 128 (1998) 1092-1098
29. Dardenne M., Pleau J.M., Nabarra B., Lefrancier P., Derrien M., Choay J., and Bach J.F. Contribution of zinc and other metals to the biological activity of the serum thymic factor. Proc. Natl. Acad. Sci. USA 79 (1982) 5370-5373
30. Dardenne M., Boukaiba N., Gagnerault M.C., Homo-Delarche F., Chappuis P., Lemonnier D., and Savino W. Restoration of the thymus in aging mice by in vivo zinc supplementation. Clin. Immunol. Immunopathol. 66 (1993) 127-135
31. Deng D.X., Cai L., Chakrabarti S., and Cherian M.G. Increased radiation-induced apoptosis in mouse thymus in the absence of metallothionein. Toxicology 134 (1999) 39-49
32. Dinarello C.A. Reduction of inflammation by decreasing production of interleukin-1 or by specific receptor antagonism. Int. J. Tissue React. 14 (1992) 65-75
33. Driessen C., Hirv K., Rink L., and Kirchner H. Induction of cytokines by zinc ions in human peripheral blood mononuclear cells and separated monocytes. Lymphokine Cytokine Res. 13 (1994) 15-20
34. Duchateau J., Delepesse G., Vrijens R., and Collet H. Beneficial effects of oral zinc supplementation on the immune response of old people. Am. J. Med. 70 (1981) 1001-1004
35. Ebadi M., and Swanson S. The status of zinc, copper, and metallothionein in cancer patients. Prog. Clin. Biol. Res. 259 (1988) 161-175
36. El Sharkawy, S.L., Abbas, N.F., Badawi, M.A., El Shaer, M.A., 2006. Metallothionein isoform II expression in hyperplastic, dysplastic and neoplastic prostatic lesions. J. Clin. Pathol., in press, doi:10.1136/jcp.2005.033746.
37. Fabris N., and Mocchegiani E. Zinc, human diseases and aging. Aging 7 (1995) 77-93
38. Fabris N., Mocchegiani E., Amadio L., Zannotti M., Licastro F., and Franceschi C. Thymic hormone deficiency in normal ageing and Down's syndrome: is there a primary failure of the thymus?. Lancet 1 (1984) 983-986
39. Fortes C., Forestiere F., Agabiti N., Fano V., Pacifici R., Virgili F., Piras G., Guidi L., Bartoloni C., Tricerri A., Zuccaio P., Ebrahim S., and Peducci C.A. The effect of zinc and vitamin A supplementation on immune response in an older population. J. Am. Geriatr. Soc. 46 (1998) 19-26
40. Fosmire G.J. Zinc toxicity. Am. J. Clin. Nutr. 51 (1990) 225-227
41. Fraker P.J., and Lill-Elghanian D.A. The many roles of apoptosis in immunity as modified by aging and nutritional status. J. Nutr. Health Aging 8 (2004) 56-63
42. Franceschi C., Chiricolo M., Licastro F., Zannotti M., Masi M., Mocchegiani E., and Fabris N. Oral zinc supplementation in Down's syndrome: restoration of thymic endocrine activity and of some immune defects. J. Ment. Defic. Res. 32 (1988) 169-181
43. Franceschi C., Valensin S., Fagnoni F., Barbi C., and Bonafe M. Biomarkers of immunosenescence within an evolutionary perspective: the challenge of heterogeneity and the role of antigenic load. Exp. Gerontol. 34 (1999) 911-921
44. Gettins P.G., and Crews B.C. Binding of epidermal growth factor to human alpha 2-macroglobulin. Significance for cytokine alpha 2-macroglobulin interactions. Ann. N. Y. Acad. Sci. 737 (1994) 383-398
45. Giacconi R., Cipriano C., Muzzioli M., Gasparini N., Orlando F., and Mocchegiani E. Interrelationships among brain, endocrine and immune response in ageing and successful ageing: role of metallothionein III isoform. Mech. Ageing Dev. 124 (2003) 371-378
46. Giacconi R., Cipriano C., Muti E., Costarelli L., Maurizio C., Saba V., Gasparini N., Malavolta M., and Mocchegiani E. Novel-209A/G MT2A polymorphism in old patients with type 2 diabetes and Atherosclerosis: relationship with inflammation (IL-6) and zinc. Biogerontology 6 (2005) 407-413
47. Gliemann J., Nykjaer A., Petersen C.M., Jorgensen K.E., Nielsen M., Andreasen P.A., Christensen E.I., Lookene A., Olivecrona G., and Moestrup S.K. The multiligand alpha 2-macroglobulin receptor/low density lipoprotein receptor-related protein (alpha 2MR/LRP). Binding and endocytosis of fluid phase and membrane-associated ligands. Ann. N. Y. Acad. Sci. 737 (1994) 20-38
48. Gonias S.L., LaMarre J., Crookston K.P., Webb D.J., Wolf B.B., Lopes M.B., Moses H.L., and Hayes M.A. Alpha 2-macroglobulin and the alpha 2-macroglobulin receptor/LRP. A growth regulatory axis. Ann. N. Y. Acad. Sci. 737 (1994) 273-290
49. Gonzales P., Alvarez R., Reguero J.R., Battalla A., Alvarez V., Cortina A., Cubero G.I., Garcia-Castro M., and Coto E. Variation in the lipoprotein receptor related protein, alpha2-macroglobulin and lipoprotein receptor-associated protein genes in relation to plasma lipid levels and risk of early myocardial infarction. Coron. Artery Dis. 13 (2002) 251-254
50. Hadden J.W. Thymic endocrinology. Ann. N. Y. Acad. Sci. 840 (1998) 352-358
51. Haq F., Mahoney M., and Koropatnick J. Signaling events for metallothionein induction. Mutat. Res. 533 (2003) 211-226
52. Heumann D., and Vischer T.L. Immunomodulation by alpha 2-macroglobulin and alpha 2-macroglobulin-proteinase complexes: the effect on the human T lymphocyte response. Eur. J. Immunol. 18 (1988) 755-760
53. Hoffman M.R., Pizzo S.V., and Weinberg J.B. Modulation of mouse peritoneal macrophage Ia and human peritoneal macrophage HLA-DR expression by alpha 2-macroglobulin "fast" forms. J. Immunol. 139 (1987) 1885-1890
54. Hopper N.L. Zinc and Metalloproteases in Health and Disease (1996), Taylor and Francis, London
55. Horn F., Wegenka U.M., Lutticken C., Yuan J., Roeb E., Boers W., Buschmann J., and Heinrich P.C. Regulation of alpha 2-macroglobulin gene expression by interleukin-6. Ann. N. Y. Acad. Sci. 737 (1994) 308-323
56. Ibs K.H., and Rink L. Zinc-altered immune function. J. Nutr. 133 5 Suppl. 1 (2003) 1452S-1456S
57. Iwata T., Incefy G.S., Tanaka T., Fernandes G., Menendez-Botet C.J., Pih K., and Good R.A. Circulating thymic hormone levels in zinc deficiency. Cell. Immunol. 47 (1979) 100-105
58. James K. Interactions between cytokines and alpha 2-macroglobulin. Immunol. Today 11 (1990) 163-166
59. Johnston C.J., Finkelstein J.N., Gelein R., and Oberdorster G. Pulmonary cytokine and chemokine mRNA levels after inhalation of lipopolysaccharide in C57BL/6 mice. Toxicol. Sci. 46 (1998) 300-307
60. Kagi J.H., and Schaffer A. Biochemistry of metallothionein. Biochemistry 27 (1988) 8509-8515
61. Kahari V.M., and Saarialho-Kere U. Matrix metalloproteinases and their inhibitors in tumour growth and invasion. Ann. Med. 31 (1999) 34-45
62. Kelly E.J., Quaife C.J., Froelick G.J., and Palmiter R.D. Metallothionein I and II protect against zinc deficiency and zinc toxicity in mice. J. Nutr. 126 (1996) 1782-1790
63. Khrestchatisky M., Jourquin J., Ogier C., Charton G., Bernard A., Tremblay E., and Rivera S. Matrix metalloproteinases and their inhibitors, modulators of neuro-immune interactions and of pathophysiological processes in the nervous system. J. Soc. Biol. 197 (2003) 133-144
64. Kolkenbrock H., Orgel D., Hecker-Kia A., Noack W., and Ulbrich N. The complex between a tissue inhibitor of metalloproteinases (TIMP-2) and 72-kDa progelatinase is a metalloproteinase inhibitor. Eur. J. Biochem. 198 (1991) 775-781
65. Kovacs D.M. Alpha 2-macroglobulin in late-onset Alzheimer's disease. Exp. Gerontol. 35 (2000) 473-479
66. Krauskopf A., and Blackburn E.H. Control of telomere growth by interactions of RAP1 with the most distal telomeric repeats. Nature 383 (1996) 354-357
67. Lazo J.S., Kuo S.M., Woo E.S., and Pitt B.R. The protein thiol metallothionein as an antioxidant and protectant against antineoplastic drugs. Chem. Biol. Interact. 111-112 (1998) 255-262
68. Lefrancois L., and Puddington L. Extrathymic intestinal T-cell development: virtual reality?. Immunol. Today 16 (1995) 16-21
69. Liang J.Y., Liu Y.Y., Zou J., Franklin R.B., Costello L.C., and Feng P. Inhibitory effect of zinc on human prostatic carcinoma cell growth. Prostate 40 (1999) 200-207
70. Liao A., Nitsch R.M., Greenberg S.M., Finckh U., Blacker D., Albert M., Rebeck G.W., Gomez-Isla T., Clatworthy A., Binetti G., Hock C., Mueller-Thomsen T., Mann U., Zuchowski K., Beisiegel U., Staehelin H., Growdon J.H., Tanzi R.E., and Hyman B.T. Genetic association of an alpha2-macroglobulin (Val1000lle) polymorphism and Alzheimer's disease. Hum. Mol. Genet. 7 (1998) 1953-1956
71. Licastro F., Chiricolo M., Mocchegiani E., Fabris N., Zannotti M., Beltrandi E., Mancini R., Parente R., Arena G., and Masi M. Oral zinc supplementation in Down's syndrome subjects decreased infections and normalized some humoral and cellular immune parameters. J. Intellect. Disabil. Res. 38 (1994) 149-162
72. Li Y., Li H., Dimasi N., McCormick J.K., Martin R., Schuck P., Schlievert P.M., and Mariuzza R.A. Crystal structure of a superantigen bound to the high-affinity, zinc-dependent site on MHC class II. Immunity 14 (2001) 93-104
73. Lysiak J.J., Hussaini I.M., and Gonias S.L. Alpha 2-macroglobulin synthesis by the human monocytic cell line THP-1 is differentiation state-dependent. J. Cell. Biochem. 67 (1997) 492-497
74. Malavolta M., Costarelli L., Giacconi R., Muti E., Bernardini G., Tesei S., Cipriano C., and Mocchegiani E. Single and three-colours flow cytometry assay for intracellular zinc ion availability in human lymphocytes with Zinpyr-1 and double immunofluorescence: relationship with metallothioneins. Cytometry 69A (2006) 1043-1053
75. Mann J.J., and Fraker P.J. Zinc pyrithione induces apoptosis and increases expression of Bim. Apoptosis 10 (2005) 369-379
76. Marcand S., Gilson E., and Shore D. A protein-counting mechanism for telomere length regulation in yeast. Science 275 (1997) 986-990
77. Maret W., and Vallee B.L. Thiolate ligands in metallothionein confer redox activity on zinc clusters. Proc. Natl. Acad. Sci. USA 95 (1998) 3478-3482
78. Massie H.R., Ofosu-Appiah W., and Aiello V.R. Elevated serum copper is associated with reduced immune response in aging mice. Gerontology 39 (1993) 136-145
79. Matoska J., Wahlstrom T., Vaheri A., Bizik J., and Grofova M. Tumor-associated alpha-2-macroglobulin in human melanomas. Int. J. Cancer 41 (1988) 359-363
80. Miller G.G., and Strittmatter W.J. Identification of human T cells that require zinc for growth. Scand. J. Immunol. 36 (1992) 269-277
81. Mills C.F. Zinc in Human Biology (1989), Springer-Verlag, London
82. Miyazaki K., Funahashi K., Numata Y., Koshikawa N., Akaogi K., Kikkawa Y., Yasumitsu H., and Umeda M. Purification and characterization of a two-chain form of tissue inhibitor of metalloproteinases (TIMP) type 2 and a low molecular weight TIMP-like protein. J. Biol. Chem. 268 (1993) 14387-14393
83. Mocchegiani E., Santarelli L., Muzzioli M., and Fabris N. Reversibility of the thymic involution and of age-related peripheral immune dysfunctions by zinc supplementation in old mice. Int. J. Immunopharmacol. 17 (1995) 703-718
84. Mocchegiani E., Verbanac D., Santarelli L., Tibaldi A., Muzzioli M., Radosevic-Stasic B., and Milin C. Zinc and metallothioneins on cellular immune effectiveness during liver regeneration in young and old mice. Life Sci. 61 (1997) 1125-1145
85. Mocchegiani E., Muzzioli M., Cipriano C., and Giacconi R. Zinc, T-cell pathways, ageing: role of metallothioneins. Mech. Ageing Dev. 106 (1998) 183-204
86. Mocchegiani E., Ciavattini A., Santarelli L., Ribaldi A., Muzzioli M., Bonazzi P., Giacconi R., Fabris N., and Garzetti G.G. Role of zinc and alpha2 macroglobulin on thymic endocrine activity and on peripheral immune efficiency (natural killer activity and interleukin 2) in cervical carcinoma. Br. J. Cancer 79 (1999) 244-250
87. Mocchegiani E., Muzzioli M., Gaetti R., Veccia S., Viticchi C., and Scalise G. Contribution of zinc to reduce CD4+ risk factor for 'severe' infection relapse in aging: parallelism with HIV. Int. J. Immunopharmacol. 21 (1999) 271-281
88. Mocchegiani E., Muzzioli M., and Giacconi R. Zinc and immunoresistance to infection in aging: new biological tools. Trends Pharmacol. Sci. 21 (2000) 205-208
89. Mocchegiani E., Muzzioli M., and Giacconi R. Zinc, metallothioneins, immune responses, survival and ageing. Biogerontology 1 (2000) 133-143
90. Mocchegiani E., Giacconi R., Cipriano C., Muzzioli M., Fattoretti P., Bertoni-Freddari C., Isani G., Zambenedetti P., and Zatta P. Zinc-bound metallothioneins as potential biological markers of ageing. Brain Res. Bull. 55 (2001) 147-153
91. Mocchegiani E., Giacconi R., Cipriano C., Gasparini N., Orlando F., Stecconi R., Muzzioli M., Isani G., and Carpene E. Metallothioneins (I+II) and thyroid-thymus axis efficiency in old mice: role of corticosterone and zinc supply. Mech. Ageing Dev. 123 (2002) 675-694
92. Mocchegiani E., Giacconi R., Cipriano C., Muzzioli M., Gasparini N., Moresi R., Stecconi R., Suzuki H., Cavalieri E., and Mariani E. MtmRNA gene expression, via IL-6 and glucocorticoids, as potential genetic marker of immunosenescence: lessons from very old mice and humans. Exp. Gerontol. 37 (2002) 349-357
93. Mocchegiani E., Muzzioli M., Giacconi R., Cipriano C., Gasparini N., Franceschi C., Gaetti R., Cavalieri E., and Suzuki H. Metallothioneins/PARP-1/IL-6 interplay on natural killer cell activity in elderly: parallelism with nonagenarians and old infected humans. Effect of zinc supply. Mech. Ageing Dev. 124 (2003) 459-468
94. Mocchegiani E., Giacconi R., Cipriano C., Muti E., Gasparini N., and Malavolta M. Are zinc-bound metallothionein isoforms (I+II and III) involved in impaired thymulin production and thymic involution during ageing?. Immun. Ageing 1 (2004) 5-9
95. Mocchegiani E., Giacconi R., Muti E., Rogo C., Bracci M., Muzzioli M., Cipriano C., and Malavolta M. Zinc, immune plasticity, aging, and successful ageing: role of metallothionein. Ann. N. Y. Acad. Sci. 1019 (2004) 127-134
96. Moroni F., Di Paolo M.L., Rigo A., Cipriano C., Giacconi R., Recchioni R., Marcheselli F., Malavolta M., and Mocchegiani E. Interrelationship among neutrophil efficiency, inflammation, antioxidant activity and zinc pool in very old age. Biogerontology 6 (2005) 271-281
97. Nagase H., and Woessner Jr. J.F. Matrix metalloproteinases. J. Biol. Chem. 274 (1999) 21491-21494
98. Ohteki T., Okuyama R., Seki S., Abo T., Sugiura K., Kusumi A., Ohmori T., Watanabe H., and Kumagai K. Age-dependent increase of extrathymic T cells in the liver and their appearance in the periphery of older mice. J. Immunol. 149 (1992) 1562-1570
99. Otvos J.D., Engeseth H.R., Nettesheim D.G., and Hilt C.R. Interprotein metal exchange reactions of metallothionein. Experientia 52 (1987) 171-178
100. Palmiter R.D. Regulation of metallothionein genes by heavy metals appears to be mediated by a zinc-sensitive inhibitor that interacts with a constitutively active transcription factor, MTF-1. Proc. Natl. Acad. Sci. USA 91 (1994) 1219-1223
101. Penkowa M., Giralt M., Moos T., Thomsen P.S., Hernandez J., and Hidalgo J. Impaired inflammatory response to glial cell death in genetically metallothionein-I- and -II-deficient mice. Exp. Neurol. 156 (1999) 149-164
102. Petersson K., Hakansson M., Nilsson H., Forsberg G., Svensson L.A., Liljas A., and Walse B. Crystal structure of a superantigen bound to MHC class II displays zinc and peptide dependence. EMBO J. 20 (2001) 3306-3312
103. Prasad A.S. Zinc and immunity. Mol. Cell Biochem. 188 (1998) 63-69
104. Prasad A.S. Effects of zinc deficiency on Th1 and Th2 cytokine shifts. J. Infect. Dis. 182 Suppl. 1 (2000) S62-S68
105. Prasad A.S., Fitzgerald J.T., Hess J.W., Kaplan J., Pelen F., and Dardenne M. Zinc deficiency in elderly patients. Nutrition 9 (1993) 218-224
106. Provinciali M., Di Stefano G., and Stronati S. Flow cytometric analysis of CD3/TCR complex, zinc, and glucocorticoid-mediated regulation of apoptosis and cell cycle distribution in thymocytes from old mice. Cytometry 32 (1998) 1-8
107. Rink L., and Gabriel P. Zinc and the immune system. Proc. Nutr. Soc. 59 (2000) 541-552
108. Rink L., and Kirchner H. Zinc-altered immune function and cytokine production. J. Nutr. 130 5S Suppl. (2000) 1407S-1411S
109. Rink L., and Seyfarth M. Characteristics of immunologic test values in the elderly. Z. Gerontol. Geriatr. 30 (1997) 220-225
110. Saha A.R., Hadden E.M., and Hadden J.W. Zinc induces thymulin secretion from human thymic epithelial cells in vitro and augments splenocyte and thymocyte responses in vivo. Int. J. Immunopharmacol. 17 (1995) 729-733
111. Sandstead H.H. Requirements and toxicity of essential trace elements, illustrated by zinc and copper. Am. J. Clin. Nutr. 61 (1995) 621S-624S
112. Sandstead H.H., Henriksen L.K., Greger J.L., Prasad A.S., and Good R.A. Zinc nutriture in the elderly in relation to taste acuity, immune response, and wound healing. Am. J. Clin. Nutr. 36 5 Suppl. (1982) 1046-1059
113. Shankar A.H., and Prasad A.S. Zinc and immune function: the biological basis of altered resistance to infection. Am. J. Clin. Nutr. 68 (1998) 447S-463S
114. Sottrup-Jensen L. Alpha-macroglobulins: structure, shape, and mechanism of proteinase complex formation. J. Biol. Chem. 264 (1989) 11539-11542
115. Starkey P.M., and Barrett A.J. Evolution of alpha 2-macroglobulin. The demonstration in a variety of vertebrate species of a protein resembling human alpha 2-macroglobulin. Biochem. J. 205 (1982) 91-95
116. Stetler-Stevenson W.G., Liotta L.A., and Kleiner Jr. D.E. Extracellular matrix 6: role of matrix metalloproteinases in tumor invasion and metastasis. FASEB J. 7 (1993) 1434-1441
117. Strickland D.K., Ashcom J.D., Williams S., Burgess W.H., Migliorini M., and Argraves W.S. Sequence identity between the alpha 2-macroglobulin receptor and low density lipoprotein receptor-related protein suggests that this molecule is a multifunctional receptor. J. Biol. Chem. 265 (1990) 17401-17404
118. Tanaka Y., Shiozawa S., Morimoto I., and Fujita T. Role of zinc in interleukin 2 (IL-2)-mediated T-cell activation. Scand. J. Immunol. 31 (1990) 547-552
119. Taylor G.A., and Blackshear P.J. Zinc inhibits turnover of labile mRNAs in intact cells. J. Cell. Physiol. 162 (1995) 378-387
120. Tissot C., and Mechti N. Molecular cloning of a new interferon-induced factor that represses human immunodeficiency virus type 1 long terminal repeat expression. J. Biol. Chem. 270 (1995) 14891-14898
121. Turnlund J.R., Durkin N., Costa F., and Margen S. Stable isotope studies of zinc absorption and retention in young and elderly men. J. Nutr. 116 (1986) 1239-1247
122. Vallee B.L., and Falchuk K.H. The biochemical basis of zinc physiology. Physiol. Rev. 73 (1993) 79-118
123. von Bulow V., Rink L., and Haase H. Zinc-mediated inhibition of cyclic nucleotide phosphodiesterase activity and expression suppresses TNF-alpha and IL-1 beta production in monocytes by elevation of guanosine 3',5'-cyclic monophosphate. J. Immunol. 175 (2005) 4697-4705
124. Wellinghausen N., Kirchner H., and Rink L. The immunobiology of zinc. Immunol. Today 18 (1997) 519-521
125. West A.K., Stallings R., Hildebrand C.E., Chiu R., Karin M., and Richards R.I. Human metallothionein genes: structure of the functional locus at 16q13. Genomics 8 (1990) 513-518
126. Williams P.D., and Day T. Antagonistic pleiotropy, mortality source interactions, and the evolutionary theory of senescence. Evolution Int. J. Org. Evolution 57 (2003) 1478-1488
127. Williams S.E., Ashcom J.D., Argraves W.S., and Strickland D.K. A novel mechanism for controlling the activity of alpha 2-macroglobulin receptor/low density lipoprotein receptor-related protein. Multiple regulatory sites for 39-kDa receptor-associated protein. J. Biol. Chem. 267 (1992) 9035-9040
128. 2+) resembles that of NO-mediated nitrosative stress, and is protected by MT-1 overexpression. Am. J. Physiol. Cell Physiol. (2006) 24
129. Ye B., Maret W., and Vallee B.L. Zinc metallothionein imported into liver mitochondria modulates respiration. Proc. Natl. Acad. Sci. USA 98 (2001) 2317-2322
130. Yu C.W., Chen J.H., and Lin L.Y. Metal-induced metallothionein gene expression can be inactivated by protein kinase C inhibitor. FEBS Lett. 420 (1997) 69-73
131. Zangger K., Oz G., Haslinger E., Kunert O., and Armitage I.M. Nitric oxide selectively releases metals from the amino-terminal domain of metallothioneins: potential role at inflammatory sites. FASEB J. 15 (2001) 1303-1305